SRF board approves new chloromethane plant to meet Indian pharma demand
SRF Limited has unveiled plans for a second chloromethane plant just two months after India imposed anti-dumping tariffs on Chinese and Russian imports.
Archives for August 10, 2016
TrialScope: customers concerned about mitigating non-compliance risks
TrialScope has added four new companies to its customer base amid a growing need for its SaaS-based clinical trial disclosure platform.
Valeant gives six months timeline for FL plant reinspection after eye drug CRL
Concerns raised by the US FDA pertaining to cGMP at a Florida facility are expected to be resolved within six months, according to Valeant.
Catalent wins early-phase contract for Arch's inhaled orphan drug
Arch Biopartners has selected Catalent to carry out studies and make batches of its orphan drug candidate AB569 for upcoming clinical trials.
CTMS market to reach $920.2m by 2021
According to a new market research report, the global CTMS Market is expected to reach $920.2m by 2021.